1 year return (CAGR)
128.13%
Liminatus Pharma, Inc. Class A Common Stock Exchange (NASDAQ, USD)
LIMN
2.92
+0.03 (+1.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
3.92M
Price/Sales
-
Ent value
4.01M
Price/Book
13.05
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.11 |
| Daily high | 3.11 |
| Daily low | 2.92 |
| Daily Volume | 11K |
| All-time high | 5.16 |
| 1y analyst estimate | - |
| Beta | 0.71 |
| EPS (TTM) | -26.36 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LIMN | S&P500 | |
| Current price drop from All-time high | -43.41% | -0.87% |
| Highest price drop | -95.17% | -56.47% |
| Date of highest drop | 6 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -63.80% | -10.65% |
| Avg time to new high | 28 days | 12 days |
| Max time to new high | 136 days | 1805 days |
News
